ammonium hydroxide has been researched along with Acquired Encephalocele in 7 studies
azane : Saturated acyclic nitrogen hydrides having the general formula NnHn+2.
Excerpt | Relevance | Reference |
---|---|---|
" We report a case of combined ecstasy/cocaine-induced fulminant hepatic failure presenting with severe rhabdomyolysis, myocardial infarction and multiorgan failure." | 3.72 | Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus). ( Bauer, E; Kramer, L; Mallek, R; Schenk, P; Steininger, R; Vigl, M, 2003) |
"Specific treatments of hyperammonemia are rarely used in liver failure when compared with urea cycle defect even though use of ammonia scavengers may help to decrease ammonemia." | 1.38 | Threshold for toxicity from hyperammonemia in critically ill children. ( Alvarez, F; Cousineau, J; Ducruet, T; Jouvet, P; Lambert, M; Mitchell, G; Nelson, J; Ozanne, B; Phan, V, 2012) |
"Patients with acute liver failure (ALF) often die of intracranial pressure (IP) and cerebral herniation." | 1.37 | Brain region-selective mechanisms contribute to the progression of cerebral alterations in acute liver failure in rats. ( Agusti, A; Boix, J; Cauli, O; Cerdán, S; Felipo, V; López-Larrubia, P; Nieto-Charques, L; Rodrigo, R, 2011) |
"Cerebral edema leading to cerebral herniation (CH) is a common cause of death in acute liver failure (ALF)." | 1.30 | Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. ( Clemmesen, JO; Hansen, BA; Kondrup, J; Larsen, FS; Ott, P, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bezinover, D | 1 |
Douthitt, L | 1 |
McQuillan, PM | 1 |
Khan, A | 1 |
Dalal, P | 1 |
Stene, J | 1 |
Uemura, T | 1 |
Kadry, Z | 1 |
Janicki, PK | 1 |
Cauli, O | 1 |
López-Larrubia, P | 1 |
Rodrigo, R | 1 |
Agusti, A | 1 |
Boix, J | 1 |
Nieto-Charques, L | 1 |
Cerdán, S | 1 |
Felipo, V | 1 |
Ozanne, B | 1 |
Nelson, J | 1 |
Cousineau, J | 1 |
Lambert, M | 1 |
Phan, V | 1 |
Mitchell, G | 1 |
Alvarez, F | 1 |
Ducruet, T | 1 |
Jouvet, P | 1 |
Kramer, L | 1 |
Bauer, E | 1 |
Schenk, P | 1 |
Steininger, R | 1 |
Vigl, M | 1 |
Mallek, R | 1 |
Clemmesen, JO | 1 |
Larsen, FS | 1 |
Kondrup, J | 1 |
Hansen, BA | 1 |
Ott, P | 1 |
Conn, HO | 2 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure: A Double- Blind, Randomized, Placebo- Controlled Study[NCT00470314] | Phase 2 | 150 participants (Actual) | Interventional | 2005-01-31 | Active, not recruiting | ||
A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury[NCT01548690] | Phase 2 | 47 participants (Actual) | Interventional | 2012-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
To evaluate the effect of OCR-002 on ammonia levels in patients with acute liver failure/severe acute liver injury (NCT01548690)
Timeframe: Baseline and 72 Hours
Intervention | Percent Change (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 41.2 |
Maximum Dose Level 6.65 g/24h | 16.6 |
Maximum Dose Level 10 g/24h | 41.8 |
Maximum Dose Level 20g/24h | 38.4 |
To evaluate the steady state pharmacokinetic and pharmacodynamic profile of OCR-002 in patients with impaired and intact renal function using urinary phenylacetylglutamine (PAGN) as a surrogate marker (NCT01548690)
Timeframe: 24 Hours after last infusion
Intervention | micrograms per millileter (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 65.6 |
Maximum Dose Level 6.65 g/24h | 32.2 |
Maximum Dose Level 10 g/24h | 33.4 |
Maximum Dose Level 20g/24h | 104.9 |
The orientation log focuses on orientation to place, time, and circumstance. There are 10 items on the orientation log, which are scored 0-3. A spontaneous correct response is awarded 3 points. A spontaneous response that is lacking or incorrect, but a correct response is provided following a logical cue is awarded 2 points. A score of 1 is given if spontaneous and cued responses are lacking or incorrect, but a correct response is provided in a recognition format. A score of 0 is given if the spontaneous, cued, or recognition format does not generate a correct answer. Scores from the 10 items are summed and the final score ranges from 0 to 30. (NCT01548690)
Timeframe: 30 Days
Intervention | units on a scale (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 23.8 |
Maximum Dose Level 6.65 g/24h | 24.0 |
Maximum Dose Level 10 g/24h | 24.0 |
Maximum Dose Level 20g/24h | 24.0 |
The West Haven Criteria (WHC) for Hepatic Encephalopathy measures the severity of encephalopathy and patient's level of consciousness. The scale ranges from 0 to 4; a minimum score of 0 represents a better outcome, and a maximum total score of 4 represents a worse outcome. A score of 0 corresponds to normal consciousness and behavior and normal neurological examination. A score of 1 corresponds to mild lack of awareness, shortened attention span, and impaired addition or subtraction; mild asterixis or tremor. A score of 2 corresponds to lethargy, disorientated or inappropriate behavior, obvious asterixis; slurred speech. A score of 3 corresponds to somnolent but arousable, gross disorientation or bizarre behavior, muscle rigidity and clonus; hyperreflexia. A score of 4 corresponds to coma and decerebrate posturing. (NCT01548690)
Timeframe: 120 hours from start of infusion
Intervention | units on a scale (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 2.4 |
Maximum Dose Level 6.65 g/24h | 3.2 |
Maximum Dose Level 10 g/24h | 1.6 |
Maximum Dose Level 20g/24h | 1.8 |
To evaluate the safety and tolerability of OCR-002 in patients with acute liver failure/severe acute liver injury (NCT01548690)
Timeframe: 30 Days
Intervention | Participants (Count of Participants) |
---|---|
Maximum Dose Level 3.33 g/24h | 0 |
Maximum Dose Level 6.65 g/24h | 0 |
Maximum Dose Level 10 g/24h | 0 |
Maximum Dose Level 20g/24h | 0 |
7 other studies available for ammonium hydroxide and Acquired Encephalocele
Article | Year |
---|---|
Fatal hyperammonemia after renal transplant due to late-onset urea cycle deficiency: a case report.
Topics: Age of Onset; Ammonia; Circle of Willis; Encephalocele; Exons; Gene Amplification; Humans; Immunosup | 2010 |
Brain region-selective mechanisms contribute to the progression of cerebral alterations in acute liver failure in rats.
Topics: Ammonia; Animals; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Cerebellum; Cerebrum; En | 2011 |
Threshold for toxicity from hyperammonemia in critically ill children.
Topics: Ammonia; Brain Edema; Child; Child, Preschool; Critical Illness; Encephalocele; Female; Humans; Hype | 2012 |
Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus).
Topics: Adult; Ammonia; Brain Edema; Cocaine; Encephalocele; Follow-Up Studies; Hepatic Encephalopathy; Huma | 2003 |
Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration.
Topics: Acute Disease; Adult; Ammonia; Arteries; Encephalocele; Female; Hepatic Encephalopathy; Humans; Live | 1999 |
Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration.
Topics: Acute Disease; Adult; Ammonia; Arteries; Encephalocele; Female; Hepatic Encephalopathy; Humans; Live | 1999 |
Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration.
Topics: Acute Disease; Adult; Ammonia; Arteries; Encephalocele; Female; Hepatic Encephalopathy; Humans; Live | 1999 |
Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration.
Topics: Acute Disease; Adult; Ammonia; Arteries; Encephalocele; Female; Hepatic Encephalopathy; Humans; Live | 1999 |
Hyperammonia and cerebral herniation: is an abnormality of ammonia metabolism responsible?
Topics: Ammonia; Brain; Encephalocele; Hepatic Encephalopathy; Humans; Intracranial Hypertension; Liver; Liv | 1999 |
Hyperammonemia and intracranial hypertension: lying in wait for patients with hepatic disorders?
Topics: Ammonia; Encephalocele; Humans; Intracranial Hypertension; Liver Failure, Acute; Predictive Value of | 2000 |